Patents by Inventor Maryvonne Laurent-Beubry

Maryvonne Laurent-Beubry has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOV protein: an anti-angiogenic agent and its use, in particular for the treatment of cancer
    Patent number: 7507712
    Abstract: The present invention relates to the use of a protein characterized in that it comprises or is constituted by the NOV protein, represented by the sequence SEQ ID NO: 2, or a fragment of this protein, providing that this fragment exhibits an angiogenesis-inhibiting activity, or any sequence derived from the sequence SEQ ID NO: 2 or from a fragment defined above, providing that this derived sequence exhibits an angiogenesis-inhibiting activity, or any sequence homologous to the sequence SEQ ID NO: 2 or to a fragment defined above, providing that this homologous sequence exhibits an angiogenesis-inhibiting activity, for the preparation of a medicament intended for the treatment of pathologies requiring the inhibition of endothelial proliferation or of pathologies requiring the inhibition of endothelial activation.
    Type: Grant
    Filed: July 30, 2004
    Date of Patent: March 24, 2009
    Assignees: Centre National de la Recherche Scientifique, INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Jean Plouēt, Maryvonne Laurent-Beubry, Cecile Martinerie-Kryceve
  • Novel anti-angiogenic agent and its use in particular within the framework of the treatment of cancer
    Publication number: 20070059314
    Abstract: The present invention relates to the use of a protein characterized in that it comprises or is constituted by the NOV protein, represented by the sequence SEQ ID NO: 2, or a fragment of this protein, providing that this fragment exhibits an angiogenesis-inhibiting activity, or any sequence derived from the sequence SEQ ID NO: 2 or from a fragment defined above, providing that this derived sequence exhibits an angiogenesis-inhibiting activity, or any sequence homologous to the sequence SEQ ID NO: 2 or to a fragment defined above, providing that this homologous sequence exhibits an angiogenesis-inhibiting activity, for the preparation of a medicament intended for the treatment of pathologies requiring the inhibition of endothelial proliferation or of pathologies requiring the inhibition of endothelial activation.
    Type: Application
    Filed: July 30, 2004
    Publication date: March 15, 2007
    Inventors: Jean Plouet, Maryvonne Laurent-Beubry, Cecile Martinerie-Kryceve